Synbio International, Inc.
SYIN
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Revenue | -39.61% | -30.43% | -7.56% | 0.79% | 103.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.61% | -30.43% | -7.56% | 0.79% | 103.01% |
| Cost of Revenue | -41.08% | -25.77% | -7.48% | 7.09% | 178.88% |
| Gross Profit | -31.50% | -44.42% | -8.24% | -20.30% | -20.63% |
| SG&A Expenses | -42.50% | -36.81% | 151.28% | 133.43% | 221.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.52% | -35.18% | 103.77% | 100.58% | 215.17% |
| Operating Income | 43.20% | 36.60% | -166.13% | -154.23% | -262.28% |
| Income Before Tax | 43.23% | 36.64% | -165.77% | -154.61% | -262.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.23% | 36.64% | -165.77% | -154.61% | -262.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.23% | 36.64% | -165.77% | -154.61% | -262.93% |
| EBIT | 43.20% | 36.60% | -166.13% | -154.23% | -262.28% |
| EBITDA | 43.96% | 37.53% | -176.50% | -163.58% | -286.25% |
| EPS Basic | 67.02% | 62.22% | -32.69% | -121.62% | -235.71% |
| Normalized Basic EPS | 80.00% | 74.42% | -90.00% | -58.33% | -136.84% |
| EPS Diluted | 67.02% | 62.22% | -32.69% | -121.62% | -235.71% |
| Normalized Diluted EPS | 80.00% | 74.42% | -90.00% | -58.33% | -136.84% |
| Average Basic Shares Outstanding | 88.86% | 102.37% | 111.07% | 16.77% | 1.80% |
| Average Diluted Shares Outstanding | 49.99% | 56.20% | 58.31% | 42.44% | 28.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |